Products for Research Use Only
RegisterLogin

Uliledlimab

CAT: 0804-HY-P99169-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99169-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer[1].
CAS Number
2378407-27-1
Product Name Alternative
TJ004309
UNSPSC
12352203
Target
CD73
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/uliledlimab.html
Purity
99.35
Solubility
10 mM in DMSO
Smiles
[Uliledlimab]
Molecular Weight
(145.04 kDa)
References & Citations
[1]Fatima Z, et al., Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors. J Immunother Precis Oncol. 2023 Feb 2;6 (2) :91-102.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MBS1563173-01Uliledlimab
GTR18338534-01Uliledlimab Antibody
DHD46602Research Grade Uliledlimab
E55B0813Uliledlimab (Reference antibody)
A138758Uliledlimab Biosimilar (Monoclonal, IgG1)
ICH5131-10mgUliledlimab Biosimilar - Research Grade
C00739-1mg*5Uliledlimab (Anti-NT5E / CD73)
ABS-243-1mgUliledlimab Biosimilar, Research Grade
GTR18697340-01Uliledlimab Human Monoclonal Antibody
047909NT5E/CD73 (uliledlimab) discontinued

Popular Products